2021
DOI: 10.1111/jocd.14508
|View full text |Cite
|
Sign up to set email alerts
|

Pustular psoriasis flare‐up in a patient with COVID‐19

Abstract: Coronavirus disease 2019 , caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), 1 has influenced a significant impact on public health, with approximately 175 million confirmed cases and more than 3 million deaths worldwide as of June 12, 2021. 2 Predominant pulmonary characteristics are the hallmark of this infection. Extrapulmonary symptoms have been reported worldwide in patients with COVID-19, including cardiovascular, 3 central nervous system (CNS), 4 renal, 5 gastrointestinal, 6 and he… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

1
21
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
6
2

Relationship

6
2

Authors

Journals

citations
Cited by 18 publications
(23 citation statements)
references
References 27 publications
1
21
0
Order By: Relevance
“…Psoriasis and seborrheic dermatitis are among the most common long‐lasting dermatologic disorders triggered or flared up following this viral infection or related vaccines. 1 , 2 Nonetheless, lichen planus has been reported less commonly after SARS‐CoV‐2 infection or COVID‐19 vaccination, necessitating its careful discussion. 3 , 4 Here, we present a case of new‐onset lichen planus in a patient who received the COVID‐19 vaccine at the same time as being infected with SARS‐CoV‐2.…”
Section: Introductionmentioning
confidence: 99%
“…Psoriasis and seborrheic dermatitis are among the most common long‐lasting dermatologic disorders triggered or flared up following this viral infection or related vaccines. 1 , 2 Nonetheless, lichen planus has been reported less commonly after SARS‐CoV‐2 infection or COVID‐19 vaccination, necessitating its careful discussion. 3 , 4 Here, we present a case of new‐onset lichen planus in a patient who received the COVID‐19 vaccine at the same time as being infected with SARS‐CoV‐2.…”
Section: Introductionmentioning
confidence: 99%
“… 1 , 2 , 3 , 4 These cutaneous adverse events have been either a new‐onset dermatologic disorder or exacerbation of the pre‐existing one. 5 , 6 The new‐onset or flare‐up of psoriasis, lichen planus, eczematous dermatitis, and many other dermatoses have been reported following COVID‐19. 7 , 8 , 9 , 10 , 11 On the contrary, dermatologic complications have also been abundantly observed after being vaccinated against SARS‐CoV‐2.…”
Section: Introductionmentioning
confidence: 99%
“…33 Reviewing the literature reveals, several cases of de novo psoriasis or disease flare up following SARS‐CoV‐2 infection. 34 , 35 , 36 Vaccination has also been reported as a triggering factor for the evolution or exacerbation of psoriasis. The vaccine‐induced psoriasis is so prevalent that the term “psoriasis vaccinalis” has been suggested for vaccine‐induced new‐onset psoriasis.…”
Section: Introductionmentioning
confidence: 99%